Zobrazeno 1 - 10
of 263
pro vyhledávání: '"Matteo Pirro"'
Publikováno v:
Current Medicinal Chemistry. 29:980-999
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors (PCSK9-I) are novel therapeutic tools to decrease cardiovascular risk. These agents work by lowering the low-density lipoprotein cholesterol (LDL-C) in hypercholesterolemic patients who
Autor:
Matteo Pirro, Željko Reiner, Amirhossein Sahebkar, Mona Alidadi, Luis E. Simental-Mendía, Tannaz Jamialahmadi, Matthew Kroh
Publikováno v:
Obesity Surgery. 31:4461-4469
PURPOSE Weight loss during post-bariatric surgery period has been linked to both reduced ASCVD mortality and overall mortality. Atherosclerosis causes arteries to lose their elasticity and become more stiff resulting in increased pulse wave velocity
Publikováno v:
Seminars in Cancer Biology. 69:337-348
Despite considerable advances in the application of liposomal drug delivery systems in cancer treatment, the clinical application of liposomal formulations has been limited by many factors. It seems that there is a wide gap between results of experim
Autor:
Fabrizio Veglia, Amy C Ferguson, Elena Tremoli, Per Eriksson, Nicholas Graham, Keira J.A. Johnston, Rona J. Strawbridge, Bruna Gigante, Philippe Giral, U DeFaire, Bengt Sennblad, Daniel J. Smith, Anders Hamsten, Steve E. Humphries, Breda Cullen, Sudhir Kurl, Jill P. Pell, Kai Savonen, Mark E.S. Bailey, Andries J. Smit, Tomi-Pekka Tomainen, Damiano Baldasarre, Matteo Pirro, Laura M. Lyall, Joey Ward, Donald M. Lyall
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Scientific Reports, 11(1):632. Nature Publishing Group
Strawbridge, R J, Johnston, K J A, Bailey, M E S, Baldassarre, D, Cullen, B, Eriksson, P, deFaire, U, Ferguson, A, Gigante, B, Giral, P, Graham, N, Hamsten, A, Humphries, S E, Kurl, S, Lyall, D M, Lyall, L M, Pell, J P, Pirro, M, Savonen, K, Smit, A J, Tremoli, E, Tomainen, T-P, Veglia, F, Ward, J, Sennblad, B & Smith, D J 2021, ' The overlap of genetic susceptibility to schizophrenia and cardiometabolic disease can be used to identify metabolically different groups of individuals ', Scientific Reports, vol. 11, no. 1, pp. 632 . https://doi.org/10.1038/s41598-020-79964-x
Scientific Reports
Scientific Reports, 11(1):632. Nature Publishing Group
Strawbridge, R J, Johnston, K J A, Bailey, M E S, Baldassarre, D, Cullen, B, Eriksson, P, deFaire, U, Ferguson, A, Gigante, B, Giral, P, Graham, N, Hamsten, A, Humphries, S E, Kurl, S, Lyall, D M, Lyall, L M, Pell, J P, Pirro, M, Savonen, K, Smit, A J, Tremoli, E, Tomainen, T-P, Veglia, F, Ward, J, Sennblad, B & Smith, D J 2021, ' The overlap of genetic susceptibility to schizophrenia and cardiometabolic disease can be used to identify metabolically different groups of individuals ', Scientific Reports, vol. 11, no. 1, pp. 632 . https://doi.org/10.1038/s41598-020-79964-x
Scientific Reports
Understanding why individuals with severe mental illness (Schizophrenia, Bipolar Disorder and Major Depressive Disorder) have increased risk of cardiometabolic disease (including obesity, type 2 diabetes and cardiovascular disease), and identifying t
Autor:
Francesco Paciosi, Amirhossein Sahebkar, Vanessa Bianconi, Elisabetta Schiaroli, Sara Benedetti, Daniela Francisci, Matteo Pirro, Massimo Raffaele Mannarino, Ettore Marini
BACKGROUND Residual inflammation is thought to promote endothelial dysfunction and cardiovascular disease risk among people living with HIV (PLWH) receiving antiretroviral therapy (ART). Whether the neutrophil-to-lymphocyte ratio (NLR), a putative ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59a4cea5e5558b4752f9e59963217568
https://hdl.handle.net/11391/1494808
https://hdl.handle.net/11391/1494808
Autor:
Giuseppe Batori, Filippo Figorilli, Vanessa Bianconi, Ettore Marini, Massimo Raffaele Mannarino, Francesco Grignani, Anna Gidari, Elena Cosentini, Matteo Pirro, Elisabetta Schiaroli, Daniela Francisci, Amirhossein Sahebkar
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine; Volume 10; Issue 22; Pages: 5456
Journal of Clinical Medicine, Vol 10, Iss 5456, p 5456 (2021)
Journal of Clinical Medicine; Volume 10; Issue 22; Pages: 5456
Journal of Clinical Medicine, Vol 10, Iss 5456, p 5456 (2021)
Background: Endothelial injury can be induced by coronavirus disease 2019 (COVID-19) and seems to exert a crucial pathogenic role in its most severe clinical manifestations. We aimed to investigate the association between brachial artery flow-mediate
Autor:
Matteo Pirro, Paola Bronzo, Vanessa Bianconi, Amirhossein Sahebkar, Maciej Banach, Massimo Raffaele Mannarino
Publikováno v:
Archives of Medical Science : AMS
Introduction: Particulate matter exposure has been associated with the appearance and severity of several diseases, including viral infections The aim of this study was to investigate whether coronavirus disease 2019 (COVID-19) cases and deaths acros
Autor:
Amirhossein Sahebkar, Tannaz Jamialahmadi, Fabrizio Montecucco, Matteo Pirro, Maciej Banach, Khalid Al-Rasadi, Željko Reiner, Dina Radenkovic, Mahdi Hatamipour
Publikováno v:
Archives of Medical Science : AMS
Archives of Medical Science, Vol 16, Iss 3, Pp 490-496 (2020)
Archives of Medical Science, Vol 16, Iss 3, Pp 490-496 (2020)
Introduction: No proven drug and no immunisation are yet available for COVID-19 disease. The SARS-CoV-2 main protease (Mpro), a key coronavirus enzyme, which is a potential drug target, has been successfully crystallised. There is evidence suggesting
Effects of statins on the biological features of mesenchymal stem cells and therapeutic implications
Autor:
Tannaz Jamialahmadi, Armita Mahdavi Gorabi, Matteo Pirro, Nasim Kiaie, Vanessa Bianconi, Amirhossein Sahebkar
Publikováno v:
Heart Failure Reviews. 26:1259-1272
Statins are well-known lipid-lowering drugs. The pleiotropic effects of statins have brought about some beneficial effects on improving the therapeutic outcomes of cell therapy and tissue engineering approaches. In this review, the impact of statins
Autor:
Vanessa Bainaconi, Maciej Banach, Tannaz Jamialahmadi, Massimo Raffaele Mannarino, Amirhossein Sahebkar, Nasim Kiaie, Matteo Pirro, Armita Mahdavi Gorabi
Publikováno v:
Progress in lipid research. 84
The 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, or statins, are administered as first line therapy for hypercholesterolemia, both in primary and secondary prevention. There is a growing body of evidence showing that beyond t